This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001 Study
ADSTILADRIN
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
European Association of Nuclear Medicine (EANM) 2024
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Bladder Cancer
Conferences
AUA 2014
Recent Abstracts
#AUA14 - Performance of multiparametric MRI for high grade prostate cancer: Correlation with whole-mount pathology - Session Highlights
May 20, 2014
#AUA14 - Multiparametric MRI for detection of radio-recurrent prostate cancer: What constitutes an optimal dataset? - Session Highlights
May 20, 2014
#AUA14 - External beam radiation therapy versus high-intensity focused ultrasound for localized prostate cancer: A matched pair comparison - Session Highlights
May 20, 2014
#AUA14 - Magnetic resonance imaging/ultrasound fusion-guided biopsy for re-targeting of atypical small acinar proliferation - Session Highlights
May 20, 2014
#AUA14 - Comparison of the Prostate Cancer Prevention Trial (PCPT) risk calculator and magnetic resonance imaging in selecting men for prostate biopsies - Session Highlights
May 19, 2014
#AUA14 - Multiparametric magnetic resonance imaging and MRI/ultrasound fusion-guided biopsy stratify patients at risk for extracapsular extension at radical prostatectomy - Session Highlights
May 19, 2014
#AUA14 - First surveillance image for patients with a small renal mass should not determine outcome: Results from the DISSRM registry - Session Highlights
May 19, 2014
#AUA14 - Experience with active surveillance (AS) in patients with renal mass ≥ 4cm: Assessment of growth kinetics and outcomes - Session Highlights
May 19, 2014
#AUA14 - Poorly functioning kidneys recover from ischemia during partial nephrectomy as well as strongly functioning kidneys - Session Highlights
May 19, 2014
#AUA14 - Malignant renal tumors are associated with worsened baseline renal function than benign masses of equal size - Session Highlights
May 19, 2014
#AUA14 - Tumor anatomic complexity predicts growth kinetics of renal masses under active surveillance - Session Highlights
May 19, 2014
#AUA14 - Active surveillance for small renal masses non-inferior to primary intervention: 5-year analysis of the multi-institutional, prospective DISSRM (Delayed Intervention and Surveillance for Small Renal Masses) Registry - Session Highlights
May 19, 2014
#AUA14 - Active surveillance, surgical management, and clinical outcomes of sporadic bilateral multifocal oncocytoma - Session Highlights
May 19, 2014
#AUA14 - Poster: Performance of early radical cystectomy and risk of pathologic upstaging in patients with stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis
May 19, 2014
#AUA14 - Effects of diabetes on renal cancer prognosis - Session Highlights
May 19, 2014
#AUA14 - Incidence of hybrid tumors found in excised renal masses: A multi-institutional analysis - Session Highlights
May 19, 2014
#AUA14 - Critical Discussion: Mesh removal in the lower urinary tract - Slide Presentation
May 19, 2014
#AUA14 - The role of obesity in the incidence of lymphatic spread, disease-free and overall survival: Data from the ARISER clinical trial - Session Highlights
May 19, 2014
#AUA14 - Poster: Patients with anatomically “simple” renal masses are more likely to be placed on active surveillance than those with anatomically “complex” lesions
May 19, 2014
#AUA14 - Survival and prognostic variables predicting survival in T4 renal cell carcinoma - Session Highlights
May 19, 2014
Page 4 of 9
Start
Prev
1
2
3
4
5
6
7
8
9
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free